Mach-1 Financial Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,410	Closed	-$496K	–	253
2023 Q3	$496K	Buy	+4,410	New	+$496K	0.21%	119
2023 Q1	–	Sell	-5,244	Closed	-$626K	–	311
2022 Q4	$626K	Buy	+5,244	New	+$626K	0.21%	84